Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,383,917
+$1,012,960 QoQ
Shares Held
3,655
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#1,813
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. LLY ranks #2 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,094 | $7,208,079 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
3,655 | $4,383,917 | |
| 3 | ABBV |
AbbVie Inc.
|
16,581 | $4,172,442 | |
| 4 | JNJ |
Johnson & Johnson
|
16,303 | $4,140,472 | |
| 5 | AMGN |
Amgen Inc
|
10,917 | $3,953,264 | |
| 6 | AZN |
Astrazeneca PLC
|
5,916 | $1,121,791 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,157 | $1,046,206 | |
| 8 | PFE |
Pfizer Inc
|
35,388 | $852,143 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,383,917 | 3,655 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,370,957 | 3,665 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $4,003,183 | 3,725 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,925,342 | 3,834 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,987,938 | 3,833 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,171,494 | 3,840 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $2,518,264 | 3,262 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,018,397 | 3,407 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $3,084,629 | 3,407 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,645,064 | 3,400 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,980,179 | 3,397 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,879,417 | 3,499 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,640,961 | 3,499 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,207,121 | 3,515 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,296,171 | 3,543 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $1,395,901 | 4,317 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,501,833 | 4,632 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,326,465 | 4,632 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,342,981 | 4,862 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,146,701 | 4,963 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,215,996 | 5,298 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $927,187 | 4,963 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $848,927 | 5,028 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $784,209 | 5,298 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $869,825 | 5,298 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $749,642 | 5,404 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||